Teza Capital Management LLC Acquires 1,777 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Teza Capital Management LLC grew its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 6.1% in the fourth quarter, Holdings Channel reports. The firm owned 30,884 shares of the company’s stock after buying an additional 1,777 shares during the quarter. Teza Capital Management LLC’s holdings in Privia Health Group were worth $604,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. First Horizon Advisors Inc. raised its position in Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after buying an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after buying an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. bought a new position in shares of Privia Health Group during the 4th quarter valued at $51,000. Quadrant Capital Group LLC grew its holdings in shares of Privia Health Group by 11.8% in the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after acquiring an additional 511 shares during the period. Finally, Nisa Investment Advisors LLC lifted its holdings in Privia Health Group by 185.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company’s stock valued at $98,000 after acquiring an additional 3,249 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Down 0.1%

Shares of Privia Health Group stock opened at $25.00 on Tuesday. The company has a market capitalization of $3.05 billion, a price-to-earnings ratio of 250.03, a PEG ratio of 3.47 and a beta of 0.87. The stock’s 50-day simple moving average is $23.38 and its 200-day simple moving average is $22.61. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.09.

Analyst Upgrades and Downgrades

PRVA has been the subject of several research reports. Robert W. Baird increased their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 15th. JMP Securities reaffirmed a “market outperform” rating and set a $29.00 target price on shares of Privia Health Group in a report on Monday, April 28th. Truist Financial lifted their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Thursday, April 10th. Needham & Company LLC reissued a “buy” rating and set a $30.00 price objective on shares of Privia Health Group in a research report on Thursday, April 10th. Finally, Barclays raised their target price on Privia Health Group from $21.00 to $23.00 and gave the stock an “equal weight” rating in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $27.38.

Insider Activity at Privia Health Group

In other Privia Health Group news, CEO Parth Mehrotra sold 15,100 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $352,283.00. Following the completion of the transaction, the chief executive officer now owns 454,281 shares of the company’s stock, valued at $10,598,375.73. This represents a 3.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO David Mountcastle sold 5,630 shares of the firm’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the transaction, the chief financial officer now owns 179,676 shares of the company’s stock, valued at approximately $4,021,148.88. The trade was a 3.04% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 51,579 shares of company stock valued at $1,226,367. 10.70% of the stock is owned by company insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.